These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6943963)

  • 1. Alternative pathways of thromboplastin-dependent activation of human factor X in plasma.
    Marlar RA; Griffin JH
    Ann N Y Acad Sci; 1981; 370():325-35. PubMed ID: 6943963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alternative extrinsic pathway of human blood coagulation.
    Marlar RA; Kleiss AJ; Griffin JH
    Blood; 1982 Dec; 60(6):1353-8. PubMed ID: 7139124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
    Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI
    J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
    Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma.
    Morrison SA; Jesty J
    Blood; 1984 Jun; 63(6):1338-47. PubMed ID: 6722352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of factor-IX-dependent prothrombinase formation--the Josso pathway--in clotting plasma.
    Xi M; Béguin S; Hemker HC
    Haemostasis; 1989; 19(6):301-8. PubMed ID: 2620866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences for the APTT due to direct action of factor XIa on factor X, resulting in bypassing factors VIII-IX.
    Kluft C; van Leuven CJ
    Thromb Res; 2015 Jan; 135(1):198-204. PubMed ID: 25467084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.
    Repke D; Gemmell CH; Guha A; Turitto VT; Broze GJ; Nemerson Y
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7623-7. PubMed ID: 2120704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive, accurate assay for extrinsic pathway inhibitor (EPI) activity in rabbit plasma: paradoxical effect of excess exogenous factor X.
    Warr TA; Rao LV; Rapaport SI
    Thromb Res; 1990 Aug; 59(4):773-82. PubMed ID: 2080494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological levels of blood coagulation factors IX and X control coagulation kinetics in an in vitro model of circulating tissue factor.
    Tormoen GW; Khader A; Gruber A; McCarty OJ
    Phys Biol; 2013 Jun; 10(3):036003. PubMed ID: 23585459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients.
    Xi M; Béguin S; Hemker HC
    Thromb Haemost; 1989 Sep; 62(2):788-91. PubMed ID: 2814925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium and manganese ions accelerate tissue factor-induced coagulation independently of factor IX.
    van den Besselaar AM
    Blood Coagul Fibrinolysis; 2002 Jan; 13(1):19-23. PubMed ID: 11994563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway.
    He R; Xiong S; He X; Liu F; Han J; Li J; He S
    Thromb Haemost; 2001 Jun; 85(6):1055-9. PubMed ID: 11434684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BLOOD CLOTTING FACTOR IN HEMOLYSATES].
    OGIWARA Y
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():779-87. PubMed ID: 14154695
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation and characterization of mouse coagulation factor X -- biophysical and enzymological properties.
    James HL; Larson PJ; Chao YB; Yan SB; Kim DJ
    Thromb Haemost; 1997 Sep; 78(3):1049-54. PubMed ID: 9308752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of freeze-dried plasma prepared from patients on oral anticoagulants.
    Brozović M; Howarth DJ; van Halem Visser LP; Loeliger EA
    J Clin Pathol; 1973 Nov; 26(11):857-63. PubMed ID: 4797328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agent.
    Ebert M; Raquet E; Schweisgut S; Schmidt PM; Weimer T
    Blood Cells Mol Dis; 2021 Jul; 89():102570. PubMed ID: 33962291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
    Nordfang O; Valentin S; Beck TC; Hedner U
    Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.